Global Microbiological Testing of Water Market Research Report by Product Type, by Parameter, by Testing Method, by Water Type, and by Region Forecast till 2035

Description

List of Tables

The Global Microbiological Testing of Water Market was valued at USD 1,508.63 million in 2025. The market is projected to expand at a CAGR of 7.6% from 2025 to 2035, driven by rising water quality concerns and increasing demand for reliable microbiological testing solutions.

Rising Awareness of Waterborne Diseases

With greater awareness of waterborne diseases like cholera and typhoid, and even hepatitis A, microbiological testing has become an integral step in routine for individuals, organizations, and companies to ensure water is safe. Frequent outbreaks of diseases and raising public concern about water safety are further fueling water source testing and certification of water testing kits.

Segment-wise Market Analysis

Product Type

Instruments: Advanced equipment enables accurate microbiological water analysis.
Reagents: Reliable reagents support consistent detection and identification.
Test Kits: Convenient kits enable rapid onsite water testing.
Filters & Membranes: Specialized membranes improve microbial separation and detection.

Parameter

Pathogenic Bacteria

Legionella: Growing concerns drive Legionella monitoring across water systems.
Vibrio spp.: Vibrio detection supports safer recreational and drinking water.
Pseudomonas aeruginosa: Testing helps identify contamination in vulnerable water systems.
Others: Other pathogens require broader microbiological screening capabilities.

Quality Indicators

Total Viable Count (TVC): TVC measures overall microbial levels in water.
Coliforms: Coliform testing remains essential for assessing contamination.
E. coli: E. coli detection indicates potential fecal contamination.
Yeast & Molds: Testing identifies fungal contamination across diverse water sources.
Fecal Enterococci: Enterococci testing supports assessment of fecal pollution.
Others: Additional indicators provide broader water quality assessment.

Testing Method

Traditional and Standard Media: Established media methods remain widely used globally.
Immunoassays: Immunoassays enable targeted detection of microbial contaminants.
Molecular Methods: Molecular techniques provide rapid and sensitive pathogen detection.
Automation: Automated systems improve testing speed, consistency and throughput.
Biosensors: Biosensors support rapid and selective microbial detection.
Conventional ATP Bioluminescence: Conventional ATP testing provides quick microbial activity assessment.
Next-Generation ATP Technology: Next-generation ATP enables faster, more sensitive monitoring.
Others: Alternative methods address specialized microbiological testing requirements.

Water Type

Industrial Processing & Building Systems Water: Monitoring supports safe and efficient facility operations.
Sewage Water: Testing helps monitor microbial contamination in sewage.
General Industrial: Industrial water testing supports process safety and compliance.
Bathing Water (Lakes & Seas): Testing protects users from recreational waterborne pathogens.
Recreational Water in Thermal Baths: Monitoring helps maintain hygienic thermal bathing environments.
Surface Water (Rivers, Lakes): Testing tracks microbial quality across surface waters.
Storm Water: Monitoring identifies microbial contamination following rainfall events.
Food & Beverage Process Water: Testing safeguards processing hygiene and product quality.
Sanitation: Microbiological checks support effective sanitation and hygiene.
Municipal (Tap Water): Municipal testing ensures safety of treated drinking water.
Bottled Water: Testing verifies microbiological quality throughout bottled water production.
Pharmaceutical & Cosmetic Process Water: Testing maintains stringent microbiological standards during manufacturing.
Energy and Oil & Gas Process Water: Monitoring supports safe industrial water management operations.

Regional Market Outlook

North America tops the microbiologically-tested water products market by introducing molecular testing and promoting building water safety. However, European countries rely on their regulatory standards and regularization testing to maintain their competitive edge. Asia-Pacific is expected to be a new water market player due to rising industrial water demand and urbanization processes. In South America and the Middle East & Africa, the municipalities expansion, development of desalination, and water reuse are among the factors for a growing market.

MicroVal Certification Strengthens Testing Portfolio

Bio-Rad has received MicroVal certification of its new methods for Listeria detection in 2026. These molecular methods were first validated by AOAC and now have double validation (AOAC + MicroVal, as of June 2026). BioRad offers PCR-based multiplex methods for rapid and accurate detection of pathogens, while also including internal controls integrated, in case of the testing done on food or the environment.

Direct-to-Consumer Testing

The increasing public interest in microbiologically safe drinking water presents a good opportunity for laboratory services to offer testing to the public beyond their regular clients (i.e. businesses that need it in the supply chain, or those required to do it under regulation). Simple home testing kits, residential sampling services and clear digital reports can help companies build direct relationships with increasingly informed urban and semi-urban consumers.

Key Report Attributes

Market Size 2025: USD 1508.63 Million
CAGR (2025-2035): 7.6%
Base Year: 2024
Market Forecast Period: 2025-2035

Industry Segmentations Growth

By Product Type: Instruments - 5.8%, Reagents - 7.6%.
By Parameter: Pathogenic Bacteria - 6.6%, Quality Indicators - 4.9%.
By Testing Method: Traditional and Standard Media - 4.8%, Immunoassays - 4.9%.
By Water Type: Industrial Processing & Building Systems Water - 6.1%, Wastewater - 5.4%.

Product Code: MRFRCnM23535CR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 CONSUMPTION & NET TRADE APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING AWARENESS OF WATERBORNE DISEASES IS DRIVING DEMAND FOR MICROBIOLOGICAL TESTING
- 4.2.2 GOVERNMENT REGULATIONS MANDATING WATER QUALITY TESTING ARE BOOSTING MARKET GROWTH
4.3 RESTRAINTS
- 4.3.1 AVAILABILITY OF ALTERNATIVE TESTING METHODS CAN LIMIT THE ADOPTION OF TRADITIONAL MICROBIOLOGICAL TESTING
- 4.3.2 HIGH COSTS ASSOCIATED WITH ADVANCED MICROBIOLOGICAL TESTING EQUIPMENT MAY HINDER MARKET GROWTH
4.4 OPPORTUNITY
- 4.4.1 RISING CONSUMER AWARENESS REGARDING SAFE DRINKING WATER CREATES A GROWING MARKET
- 4.4.2 EXPANDING WATER TREATMENT INDUSTRIES PRESENT NEW AVENUES FOR TESTING SERVICES
4.5 CHALLENGES
- 4.5.1 INCREASING COMPETITION FROM LOW-COST TESTING SOLUTIONS MAY THREATEN MARKET SHARE OF ESTABLISHED PLAYERS
- 4.5.2 RAPID TECHNOLOGICAL ADVANCEMENTS COULD MAKE EXISTING TESTING METHODS OBSOLETE

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS
- 5.1.1 PARTICIPANTS
  - 5.1.1.1 COMPONENT ANALYSIS
  - 5.1.1.2 LAB TESTING
  - 5.1.1.3 END-USERS
- 5.1.2 VALUE PERCOLATION ACROSS THE CHAIN
- 5.1.3 INTEGRATION LEVELS
- 5.1.4 KEY ISSUES ADDRESSED
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 THREAT OF SUBSTITUTES
- 5.2.3 BARGAINING POWER OF SUPPLIERS
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 TECHNOLOGICAL ADVANCEMENTS
5.4 ADJACENT MARKET ANALYSIS
5.5 REGULATORY FRAMEWORK
- 5.5.1 GOVERNMENTAL POLICIES
- 5.5.2 ENVIRONMENTAL CONSIDERATION
5.6 R&D UPDATE
- 5.6.1 CURRENT SCENARIO
- 5.6.2 FUTURE ROADMAP
- 5.6.3 CHALLENGES
- 5.6.4 NOVEL APPLICATIONS
- 5.6.5 KEY DEVELOPMENTS
5.7 PESTLE ANALYSIS
5.8 SHARE OF TESTING SITES (IN %)
- 5.8.1 IN-HOUSE TESTING
- 5.8.2 OUTSOURCED TO SERVICE LABS
- 5.8.3 OUTSOURCED TO GOVERNMENT LABS
5.9 EMERGING PATHOGENIC PARAMETERS FOR WATER TESTING
- 5.9.1 NONTUBERCULOUS MYCOBACTERIA (NTM)
- 5.9.2 ANTIMICROBIAL-RESISTANT (AMR) BACTERIA
- 5.9.3 CARBAPENEM-RESISTANT ENTEROBACTERALES (CRE)
- 5.9.4 EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)-PRODUCING BACTERIA
- 5.9.5 OTHER EMERGING PATHOGENIC PARAMETERS

6 GLOBAL MICROBIOLOGICAL TESTING OF WATER MARKET, BY PRODUCT TYPE

6.1 INTRODUCTION
6.2 INSTRUMENTS
6.3 REAGENTS
6.4 TEST KITS
6.5 FILTERS & MEMBRANES

7 GLOBAL MICROBIOLOGICAL TESTING OF WATER MARKET, BY PARAMETER

7.1 INTRODUCTION
7.2 PATHOGENIC BACTERIA
- 7.2.1 LEGIONELLA
- 7.2.2 VIBRIO SPP.
- 7.2.3 PSEUDOMONAS AERUGINOSA
- 7.2.4 OTHERS
7.3 QUALITY INDICATORS
- 7.3.1 TOTAL VIABLE COUNT (TVC / TVO)
- 7.3.2 COLIFORMS
- 7.3.3 E. COLI
- 7.3.4 YEAST & MOLDS
- 7.3.5 FECAL ENTEROCOCCI
- 7.3.6 OTHERS

8 GLOBAL MICROBIOLOGICAL TESTING OF WATER MARKET, BY TESTING METHOD

8.1 INTRODUCTION
8.2 TRADITIONAL AND STANDARD MEDIA
8.3 IMMUNOASSAYS
8.4 MOLECULAR METHODS
8.5 AUTOMATION
8.6 BIOSENSORS
8.7 ATP TESTING (BIOLUMINESCENCE)
- 8.7.1 CONVENTIONAL ATP BIOLUMINESCENCE
- 8.7.2 NEXT-GENERATION ATP TECHNOLOGY
8.8 OTHERS

9 GLOBAL MICROBIOLOGICAL TESTING OF WATER MARKET, BY WATER TYPE

9.1 INTRODUCTION
9.2 INDUSTRIAL PROCESSING & BUILDING SYSTEMS WATER
9.3 WASTEWATER
- 9.3.1 SEWAGE WATER
- 9.3.2 GENERAL INDUSTRIAL
9.4 BATHING WATER (LAKES & SEAS)
9.5 RECREATIONAL WATER IN THERMAL BATHS
9.6 ENVIRONMENTAL WATER
- 9.6.1 SURFACE WATER (RIVERS, LAKES)
- 9.6.2 STORM WATER
9.7 FOOD & BEVERAGE PROCESS WATER AND SANITATION
9.8 DRINKING WATER
- 9.8.1 MUNICIPAL (TAP WATER)
- 9.8.2 BOTTLED WATER
9.9 PHARMACEUTICAL & COSMETIC PROCESS WATER
9.10 ENERGY AND OIL & GAS PROCESS WATER

10 GLOBAL MICROBIOLOGICAL TESTING OF WATER MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 US
- 10.2.2 CANADA
- 10.2.3 MEXICO
10.3 EUROPE
- 10.3.1 GERMANY
- 10.3.2 UK
- 10.3.3 FRANCE
- 10.3.4 RUSSIA
- 10.3.5 ITALY
- 10.3.6 SPAIN
- 10.3.7 REST OF EUROPE
10.4 ASIA-PACIFIC
- 10.4.1 CHINA
- 10.4.2 INDIA
- 10.4.3 JAPAN
- 10.4.4 SOUTH KOREA
- 10.4.5 MALAYSIA
- 10.4.6 THAILAND
- 10.4.7 INDONESIA
- 10.4.8 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
- 10.5.1 BRAZIL
- 10.5.2 ARGENTINA
- 10.5.3 REST OF SOUTH AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 GCC COUNTRIES
- 10.6.2 SOUTH AFRICA
- 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 COMPANY MARKET SHARE ANALYSIS, 2025 (%)
11.3 COMPETITIVE BENCHMARKING
11.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL, 2025
11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.5.1 NEW PRODUCT/SERVICE LAUNCH
- 11.5.2 MERGER AND ACQUISITION
- 11.5.3 AGREEMENT
- 11.5.4 INVESTMENT

12 COMPANY PROFILES

12.1 THERMO FISHER SCIENTIFIC INC.
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGY
12.2 IDEXX LABORATORIES, INC.
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGY
12.3 AGILENT TECHNOLOGIES, INC.
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 SWOT ANALYSIS
- 12.3.6 KEY STRATEGY
12.4 BIO-RAD LABORATORIES, INC.
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 SWOT ANALYSIS
- 12.4.6 KEY STRATEGY
12.5 MERCK KGAA
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 SWOT ANALYSIS
- 12.5.6 KEY STRATEGY
12.6 HACH COMPANY
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 SWOT ANALYSIS
- 12.6.6 KEY STRATEGY
12.7 BIOMERIEUX SA
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 SWOT ANALYSIS
- 12.7.6 KEY STRATEGY
12.8 NEOGEN CORPORATION
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 SWOT ANALYSIS
- 12.8.6 KEY STRATEGY
12.9 HYGIENA LLC
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PRODUCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 SWOT ANALYSIS
- 12.9.6 KEY STRATEGY
12.10 R-BIOPHARM AG
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL OVERVIEW
- 12.10.3 PRODUCTS OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 SWOT ANALYSIS
- 12.10.6 KEY STRATEGY
12.11 QIAGEN N.V.
- 12.11.1 COMPANY OVERVIEW
- 12.11.2 FINANCIAL OVERVIEW
- 12.11.3 PRODUCTS OFFERED
- 12.11.4 KEY DEVELOPMENTS
- 12.11.5 SWOT ANALYSIS
- 12.11.6 KEY STRATEGY
12.12 PROMEGA CORPORATION
- 12.12.1 COMPANY OVERVIEW
- 12.12.2 FINANCIAL OVERVIEW
- 12.12.3 PRODUCTS OFFERED
- 12.12.4 KEY DEVELOPMENTS
- 12.12.5 SWOT ANALYSIS
- 12.12.6 KEY STRATEGY
12.13 DIATHEVA S.R.L.
- 12.13.1 COMPANY OVERVIEW
- 12.13.2 FINANCIAL OVERVIEW
- 12.13.3 PRODUCTS OFFERED
- 12.13.4 KEY DEVELOPMENTS
- 12.13.5 SWOT ANALYSIS
- 12.13.6 KEY STRATEGY
12.14 HARDY DIAGNOSTICS
- 12.14.1 COMPANY OVERVIEW
- 12.14.2 FINANCIAL OVERVIEW
- 12.14.3 PRODUCTS OFFERED
- 12.14.4 KEY DEVELOPMENTS
- 12.14.5 SWOT ANALYSIS
- 12.14.6 KEY STRATEGY
12.15 LAMOTTE COMPANY
- 12.15.1 COMPANY OVERVIEW
- 12.15.2 FINANCIAL OVERVIEW
- 12.15.3 PRODUCTS OFFERED
- 12.15.4 KEY DEVELOPMENTS
- 12.15.5 SWOT ANALYSIS
- 12.15.6 KEY STRATEGY